PackHealth: Asthma Engagement Tool



Status:Completed
Conditions:Asthma
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - Any
Updated:10/10/2018
Start Date:August 2015
End Date:September 2016

Use our guide to learn which trials are right for you!

Assessing the Impact of a Patient-Clinician Engagement Tool on Patient Reported Outcomes and Engagement in Asthma

The purpose of this study is to test the impact of an innovative patient engagement solution
on patient's quality of life and asthma-related outcomes, and evaluate the correlation
between a patient reported outcome measure and clinical outcomes.

Patient engagement is a critical part of improving patient care and outcomes. Current patient
engagement strategies only focus on the patient-physician interaction and have been shown to
be ineffective.

The need for a comprehensive approach to patient engagement is no different among patients
with asthma as it is in any other chronic condition. Patients with asthma must make
complicated health decisions daily that impact their social and occupational activities,
quality of life, and treatment adherence. Obtaining, communicating, processing, and
understanding non- biased health information are crucial in making appropriate and informed
treatment decisions.

Pack Health LLC and Duke will develop a patient engagement toolkit known as "Packs" to help
empower and engage patients. These disease-specific, evidence-based kits are scientifically
designed to improve patient involvement in their own care. Each Pack draws on the science of
change management and patient activation and contains three categories of materials

Inclusion Criteria:

- Patients with a physician diagnosis of asthma for at least the previous 12 months.

- Asthma that is not well controlled by NAEPP guidelines.

- Ability and willingness to provide informed consent

Exclusion Criteria:

- Significant alcohol consumption of more than three alcoholic drinks per day or active
substance abuse.

- Chronic disease (other than asthma) that in the opinion of the investigator would
prevent participation in the trial or put the participant at risk by participation
e.g. chronic diseases of the lung (other than asthma), heart, liver, kidney, endocrine
or nervous system or immunodeficiency that are not well addressed or controlled.

- A diagnosis of cancer with ongoing treatment.

- Any terminal illness or conditions that results in a life expectancy less than one
year.
We found this trial at
1
site
Durham, North Carolina 27704
Principal Investigator: Njira Lugogo
?
mi
from
Durham, NC
Click here to add this to my saved trials